With the shine of amyloid fading, tau is a rising star in Alzheimer’s

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Sonya Miller follows the science. In 2017, she followed it so completely and with such focus into a crowded conference room that she accidentally sat next to the CEO of TauRx Pharmaceuticals and talked herself into a … Read more

What now? Alzheimer’s drugmakers ponder the path to approval

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Last week, Medicare rendered a fateful decision that’s become the latest flashpoint in Biogen’s ongoing saga with Aduhelm. As part of a new finalized policy, the Centers for Medicare and Medicaid Services (CMS) will limit coverage for … Read more